STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
STAT · September 28, 2026

Source:STAT
Comments
No comments yet.
Sign in to join the conversation.
Sign In
No comments yet.
Sign in to join the conversation.
Sign In